Sparsentan
Generic name: Sparsentan
Brand names: Filspari
Dosage form: oral tablet (200 mg; 400 mg)
Drug class:
Miscellaneous cardiovascular agents
Usage of Sparsentan
Sparsentan is used to lower levels of protein in the urine (proteinuria) in adults with a kidney disease called primary immunoglobulin A nephropathy.
Sparsentan is available only from a certified pharmacy under a special program. You must be registered in the program and understand the risks and benefits of sparsentan.
Sparsentan may also be used for purposes not listed in this medication guide.
Sparsentan side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Sparsentan may cause serious liver problems. Stop taking sparsentan and call your doctor right away if you have nausea, vomiting, loss of appetite, right-sided upper stomach pain, tiredness, weight loss, jaundice, dark urine, fever, or itching.
Sparsentan may cause serious side effects. Call your doctor at once if you have:
Common side effects of sparsentan may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Sparsentan
Some drugs should not be used with sparsentan. Your treatment plan may change if you also use:
Tell your doctor if you have ever had:
May cause birth defects. Do not use if you are pregnant. You must use effective birth control while using sparsentan and for at least 1 month after your last dose. Tell your doctor if you become pregnant.
Ask your doctor about the best form of birth control while you are using sparsentan.
You will need to have a negative pregnancy test before starting this treatment. You will need to take a pregnancy test during and after treatment with sparsentan.
Do not breastfeed.
Relate drugs
- Corlanor
- Camzyos
- Demser
- Dibenzyline
- Filspari
- Inpefa
- Ivabradine
- Mavacamten
- Metyrosine
- Midodrine
- Orvaten
- Phenoxybenzamine
- Phentolamine
- Proamatine
- Regitine
- Sotagliflozin
- Sparsentan
How to use Sparsentan
Usual Adult Dose for Primary Immunoglobulin A Nephropathy:
Initial dose: 200 mg orally once a day for 14 daysMaintenance dose: Following initial dose, increase to 400 mg orally once a day, as toleratedComments:-Consider dose titration when resuming treatment after interruption: Start with initial dose for 14 days, then increase to recommended maintenance dose. Use: To reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression (generally a urine protein-to-creatinine ratio of 1.5 g/g or greater); indication is based on accelerated approval, and continued approval may be contingent on confirmatory clinical trial.
Warnings
Do not use if you are pregnant. Use effective birth control.
Tell your doctor about all your other medicines. Some drugs should not be used with sparsentan.
Sparsentan may cause serious liver problems. Stop taking sparsentan and call your doctor right away if you have nausea, vomiting, loss of appetite, right-sided upper stomach pain, tiredness, weight loss, jaundice, dark urine, fever, or itching.
Sparsentan is available only under a special program. You must be registered in the program and understand the risks and benefits of this medicine.
What other drugs will affect Sparsentan
Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.
Avoid taking an antacid within 2 hours before or after you take sparsentan.
Tell your doctor about all your current medicines. Many drugs can affect sparsentan, especially:
This list is not complete. Other drugs may affect sparsentan, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions